Nikhil Lalwani is PRESIDENT & CEO of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 468,179 shares of ANIP, which is worth approximately $32.4 Million. The most recent transaction as insider was on Mar 23, 2022, when has been sold 17,454 shares (Common Stock) at a price of $27.03 per share, resulting in proceeds of $471,782. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 468K
26.41% 3M change
18.77% 12M change
Total Value Held $32.4 Million

Nikhil Lalwani Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 23 2022
SELL
Payment of exercise price or tax liability
$471,782 $27.03 p/Share
17,454 Reduced 10.29%
152,196 Common Stock
Mar 21 2022
BUY
Open market or private purchase
$200,033 $27.69 p/Share
7,224 Added 4.08%
169,650 Common Stock
Sep 08 2021
SELL
Payment of exercise price or tax liability
$72,671 $28.2 p/Share
2,577 Reduced 1.56%
162,426 Common Stock
Mar 23 2021
BUY
Grant, award, or other acquisition
-
136,495 Added 45.27%
165,003 Common Stock
NL

Nikhil Lalwani

PRESIDENT & CEO
Baudette, MN

Track Institutional and Insider Activities on ANIP

Follow ANI PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIP shares.

Notify only if

Insider Trading

Get notified when an Ani Pharmaceuticals Inc insider buys or sells ANIP shares.

Notify only if

News

Receive news related to ANI PHARMACEUTICALS INC

Track Activities on ANIP